Cited 0 times in
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.